Typhoid Fever Vaccines Market, By Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine, and Others), By Route of Administration (Oral and Parenteral), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2029

Typhoid fever vaccines are primarily used in order to prevent typhoid fever. Typhoid fever is infectious disease which is cause by gram-negative bacterium salmonella Typhi. This disease is transmitted basically through the contaminated and unhygienic water as well as food. Symptoms of typhoid fever include nausea, prolonged fever, headache, and constipation. Prevalence this disease is mostly occur in the low-income countries; facing problems associated with the poor sanitation.

Increasing prevalence of typhoid fever across the globe especially in the developing countries is creating demand for typhoid fever vaccines and in turn driving growth of the typhoid fever vaccines market. In addition, increasing government initiatives in order to create awareness regarding typhoid vaccine, coupled with growth in access of new vaccines globally are another factors expected to propel growth of the target market over the forecast period. However, less availability of typhoid fever vaccines in the remote areas is major factor anticipated to restrain growth of the typhoid fever vaccines market in the near future.

typhoid fever vaccines market has been segmented on the basis of vaccine type, route of administration, and region.

On the basis of vaccine type, the target market is classified into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. On the basis of route of administration, the typhoid fever vaccines market is classified into oral and parenteral. The oral route of administration segment is expected to dominate in the target market in terms of revenue in the near future.

On the basis of region, the global market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific typhoid fever vaccines market is expected to account for major revenue share as compared to that of other regions. This can be attributed to presence of key typhoid fever vaccine manufacturers in the countries of the region. For instance, Bharat Biotech and Bio-Med Private Limited are typhoid fever vaccine manufacturer present in the Asia Pacific.

Key players operating in the typhoid fever vaccine market includes GlaxoSmithKline Plc., Sanofi SA, Bharat Biotech International Limited, Bio-Med Pvt. Ltd., PT Bio Farma, PaxVax, Inc., Shanghai Institute of Biological Products Co., Ltd., and Prokarium Ltd.

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
   • PORTER’s
   • Investment Outlook
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for Typhoid Fever Vaccines Strategies
     • Key Questions this Study will Answer

     • By Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine, and Others)

       By Route of Administration (Oral and Parenteral)

       By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) 

   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Overview
   • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
   • Y-o-Y Growth Analysis (%), 2020 – 2030
   • Regional Trends
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Regional Analysis
   • Regional Revenue Analysis
   • Regional By segment Analysis
   • Reasons for regional growth
   • Key Player of particular region
   • Countries Include in the report:

1. • • North America (U.S., Canada)
     • Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
     • Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
     • Latin America (Brazil, Mexico, Rest of Latin America)
     • Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
   • Competitive Overview
   • Competitive Benchmarking
   • Market Share Analysis
   • Key Developments In The Global Typhoid Fever Vaccines Market
   • Key Developments: Mergers & Acquisitions
   • Key Developments: Collaboration
   • Key Developments: Contracts & Agreements
   • Key Developments: Expansion
   • Key Developments: Product Developments
2. Company Profiles

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Performance
• Business Strategies
• SWOT Analysis

• • GlaxoSmithKline Plc., Sanofi SA

  • Bharat Biotech International Limited

  • Bio-Med Pvt. Ltd.

  • PT Bio Farma, PaxVax, Inc.

  • Shanghai Institute of Biological Products Co., Ltd.,

  • Prokarium Ltd.

1. The Last Word
   • Future Impact
   • About Us
   • Contact